1. |
Global report on diabetes, 2016. World Health Organization (2016). http://www.who.int/diabetes/global-report/en/.
|
2. |
Papatheodorou K, Papanas N, Banach M, et al. Complications of diabetes 2016. J Diabetes Res, 2016, 2016: 6989453.
|
3. |
White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet, 2009, 373(9677): 1808-1817.
|
4. |
Yadav K, Young S, Finger EB, et al. Significant arterial complications after pancreas transplantation—A single-center experience and review of literature. Clin Transplant, 2017, 31(10): e13070.
|
5. |
Kaplan B, Wang Z, Abecassis MM, et al. Frequency of hyperkalemia in recipients of simultaneous pancreas and kidney transplants with bladder drainage. Transplantation, 1996, 62(8): 1174-1175.
|
6. |
Montford JR, Linas S. How dangerous is hyperkalemia? J Am Soc Nephrol, 2017, 28(11): 3155-3165.
|
7. |
任生生, 许亮亮, 宋涂润, 等. 胰肾联合移植治疗糖尿病肾功能衰竭五例临床分析. 中华器官移植杂志, 2019, 40(5): 272-276.
|
8. |
Grochowiecki T, Gałązka Z, Madej K, et al. Early complications related to the transplanted kidney after simultaneous pancreas and kidney transplantation. Transplant Proc, 2014, 46(8): 2815-2817.
|
9. |
Khubutia MS, Pinchuk AV, Dmitriev IV, et al. Surgical complications after simultaneous pancreas-kidney transplantation: A single-center experience. Asian J Surg, 2016, 39(4): 232-237.
|
10. |
Dholakia S, Oskrochi Y, Easton G, et al. Advances in pancreas transplantation. J R Soc Med, 2016, 109(4): 141-146.
|
11. |
Orsenigo E, Fiorina P, Dell ’Antonio G, et al. Gastrointestinal bleeding from enterically drained transplanted pancreas. Transpl Int, 2005, 18(3): 296-302.
|
12. |
Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ, 2016, 40(4): 480-490.
|
13. |
Rangel EB. The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation. Expert Opin Drug Metab Toxicol, 2012, 8(12): 1531-1548.
|
14. |
Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol, 2009, 4(2): 481-508.
|
15. |
Hoorn EJ, Walsh SB, McCormick JA, et al. Pathogenesis of calcineurin inhibitor-induced hypertension. J Nephrol, 2012, 25(3): 269-275.
|
16. |
Terker AS, Zhang C, McCormick JA, et al. Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab, 2015, 21(1): 39-50.
|
17. |
Kovesdy CP. Management of hyperkalemia: An update for the internist. Am J Med, 2015, 128(12): 1281-1287.
|
18. |
Velázquez H, Perazella MA, Wright FS, et al. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med, 1993, 119(4): 296-301.
|
19. |
Mohan S, Jaitly M, Pogue VA, et al. Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia. J Antimicrob Chemother, 2009, 64(4): 850-852.
|
20. |
Tainio J. Calcineurin inhibitor-associated electrolyte disturbances after pediatric renal transplantation: Could fludrocortisone therapy have a role? Pediatr Transplant, 2018, 22(2): e13097.
|
21. |
Jadoul M, Ferrant A, De Plaen JF, et al. Mineralocorticoids in the management of primary adrenocortical insufficiency. J Endocrinol Invest, 1991, 14(2): 87-91.
|
22. |
Amador CA, Bertocchio JP, Andre-Gregoire G, et al. Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration. Kidney Int, 2016, 89(2): 354-362.
|
23. |
Ali SR, Shaheen I, Young D, et al. Fludrocortisone—a treatment for tubulopathy post-paediatric renal transplantation: A national paediatric nephrology unit experience. Pediatr Transplant, 2018, 22(2): e13134.
|